Status:
COMPLETED
A U.S Post Approval Study Evaluating the SYNERGY XLV (MEGATRON) Stent System
Lead Sponsor:
Boston Scientific Corporation
Conditions:
Atherosclerosis
Heart Diseases, Coronary
Eligibility:
All Genders
18+ years
Brief Summary
This is a post-market, standard of care, real-world observational study to assess the clinical outcomes of the SYNERGY XLV (MEGATRON) Coronary Stent System for the treatment of subjects with atheroscl...
Eligibility Criteria
Inclusion
- Patient requires treatment with a SYNERGY XLV (Megatron) stent
Exclusion
- Planned treatment with a non-SYNERGY stent
Key Trial Info
Start Date :
April 14 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 18 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04807439
Start Date
April 14 2021
End Date
August 18 2023
Last Update
October 23 2023
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale University
New Haven, Connecticut, United States, 06520
2
Clearwater Cardiovascular Consultants
Clearwater, Florida, United States, 33756
3
Beth Israel Deaconness Medical Center
Boston, Massachusetts, United States, 02215
4
North Kansas City Hospital
Kansas City, Missouri, United States, 64116